Showing results (861-870 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|February 29, 2024
Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinomaWei Wei, Linqing Tian, Xiaoyan Zheng, et al.
Oncoimmunology|March 6, 2024
Trial watch: bispecific antibodies for the treatment of relapsed or refractory large B-cell lymphomaGiulio Cassanello, Alejandro Luna de Abia, Lorenzo Falchi
Oncoimmunology|February 29, 2024
Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancerJin Su, Xinyuan Mao, Lingzhi Wang, et al.
Oncoimmunology|October 23, 2023
PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinomaNiklas Klümper, Lennert Wüst, Jonas Saal, et al.
Oncoimmunology|August 3, 2023
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by OxaliplatinNanumi Han, Haruka Wada, Takuto Kobayashi, et al.
Oncoimmunology|August 18, 2023
TNBC-derived Gal3BP/Gal3 complex induces immunosuppression through CD45 receptorAnnat Raiter, Julia Lipovetsky, Asaf Stenbac, et al.
Oncoimmunology|June 26, 2023
Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancerErnesto Lopez, Sofía Hidalgo, Eduardo Roa, et al.
Oncoimmunology|June 8, 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell functionJill Fenaux, Xin Fang, Yao-Ming Huang, et al.
Oncoimmunology|June 7, 2023
Trial watch: chemotherapy-induced immunogenic cell death in oncologyJenny Sprooten, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Oncoimmunology|June 1, 2023
CD8 T cell-mediated depletion of HBV surface-antigen-expressing, bilineal-differentiated liver carcinoma cells generates highly aggressive escape variantsNa Qiu, Akshaya Srikanth, Medhanie Mulaw, et al.
Pageof 379